Please assess the completion status of the following clinical trial:

Trial Title: Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with type 2 diabetes mellitus~* Patients age 35-75~* Metabolic control of diabetes by diet or oral treatment (unmodified in the last 3 months)~* Blood pressure \<160/100 mmHg, including subjects with controlled hypertension, treated with ACE-inhibitors/sartans, unmodified in the last 3 months~Exclusion Criteria:~* Participation in another study with an investigational drug or device~* HbA1c \>12%~* Alterations during ECG stress examination~* Current use of nitrate agents~* Proliferative retinopathy~* Patients with history of cardiovascular and malignant disease~* Psychosocial disturbance~* Alcohol or drug dependence~* Allergy or hypersensitivity to sildenafil or other Phosphodiesterase inhibitors.

- Gender: MALE
- Minimum Age: 35 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Sildenafil 100 mg
- 2 (Type: PLACEBO_COMPARATOR): Placebo 100 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).